Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Compounding pharmacies can resume making tirzepatide
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.
1d
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
2d
FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs
The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...
2d
on MSN
FDA Reversal on Knockoff GLP-1 Drugs Brings Confusion, and Few Answers
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Shot multiple times in Vegas
Gets minimum 28 years
Exotic cat caught in suburb
US Navy aircraft crashes
US adults loneliness survey
Trump Media stock plunges
Campaign denies plagiarism
Cereal dyes protested
Testifies before Congress
Grants honorable discharges
PA gun restrictions ruling
Revives Fox News lawsuit
Salton Sea conservation
Parents sue MA school
SCOTUS rejects appeal
Felon voting rights upheld
$750M US chips grant
$1.4B renovation deal OK'd
Ownership stake approved
To return to Atlanta in 2028
GA hand-count rule blocked
Must face US state lawsuits
Broadband data caps probe
'Click to cancel' finalized
Had benign cyst removed
SpaceX sues CA regulators
To invest in nuclear reactors
Ordered to pay $15 million
MI shooter drill settlement
Out of disaster loan money
Related topics
Eli Lilly and Company
Zepbound
Feedback